Alamance Oncology Hematolgy Associates — Burlington, North Carolina

Alamance Oncology Hematolgy Associates is a clinical research site located in Burlington, North Carolina, United States 27599.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Alamance Oncology Hematolgy Associates has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Adenocarcinoma.

Sponsors: ImmunoGenesis.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alamance Oncology Hematolgy Associates?

Alamance Oncology Hematolgy Associates has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alamance Oncology Hematolgy Associates conducted?

Alamance Oncology Hematolgy Associates has 1 clinical trials on record. Their work covers Pancreatic Adenocarcinoma.

Is Alamance Oncology Hematolgy Associates accredited by Crixeo Health?

Alamance Oncology Hematolgy Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alamance Oncology Hematolgy Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.